Page 174 - CW E-Magazine (31-10-2023)
P. 174
Special Report Special Report
(NIFTY PHARMA), which consists of profi t while meeting the sustainability gets for reducing its environmental 100% renewable energy by the year
20 pharmaceutical companies operat- goals to protect the planet. impact and improving social well-being. 2030 and carbon neutrality in its opera-
ing in various segments. tions (scope 1 and scope 2 emissions)
Sun Pharmaceutical Industries The company has implemented a by the same year. It also aims to reduce
Many of these pharmaceutical com- Sun Pharma is the largest Indian number of initiatives to reduce its envi- its water consumption by 25% by 2030.
panies are publishing their sustainabi- pharmaceutical company with sales of ronmental impact and improve social The company has invested in a num-
lity reports regularly. over Rs. 43,200 crores in 2022-23. The well-being. Divi’s Laboratories has ber of renewable energy projects, such
company has set ambitious sustainabi- adopted green chemistry principles in as solar panels and wind power. Water
Sustainability efforts lity targets in line with the United its manufacturing processes, which conservation projects like rainwater
Indian pharmaceutical companies Nations Sustainable Development Goals have led to signifi cant reductions in harvesting and water recycling have
have focused on attaining sustainabi- (UN SDGs), including reducing its water and energy consumption, as well also been implemented. DRL is also
lity in their operations through various carbon emissions by 35% by the year as waste generation. It has also invested working to reduce its waste generation
means and measures, just like other 2030. It has set a target to reduce its in renewable energy sources, such and promote sustainable waste man-
companies in various industry sectors. water consumption by 10% by 2025 and as, solar and wind power, to meet its agement practices. The company has
Sustainability has become an important achieving water neutrality by the year energy requirements. The company has set a target to achieve zero waste from
operational aspect in pharmaceutical 2030. The company is implementing also implemented a number of water its manufacturing facilities to landfi ll
manufacturing practices. a number of initiatives to achieve this conservation measures, such as rainwa- by the year 2030.
target, including rainwater harvesting, ter harvesting and recycling. The com-
The important sustainability efforts recycling wastewater, and reducing water pany’s CSR initiatives focus on areas Cipla
may be summarised as described here. as, use of energy effi cient equip- Reduced costs – Manufacturing wastage in its manufacturing processes. such as education, healthcare and rural Cipla, with sales of over Rs. 22,400
1. Renewable energy use – Many ment and lighting, optimization of costs are reduced by reducing Sun Pharma has set a target to dispose development. crores in 2022-23, has implemented
Indian pharmaceutical companies are production schedules, etc. energy consumption, water consum- of 30% of its hazardous waste through a number of initiatives to reduce its
using renewable energy obtained 5. Promoting green chemistry – Deve- ption and waste generation. Thus, co-processing by the year 2025. The Some of the key achievements of environmental impact, improve social
through solar and wind sources, to lopment of new drugs and manu- the companies can save money and company is also working to reduce its the company’s sustainability efforts in well-being, and promote good gover-
reduce their carbon footprint. facturing processes that are more increase their profi t. overall waste generation by improving the past fi ve years include: reduction in nance. Cipla is also compliant with
2. Reduction in water consumption – environmentally friendly or green Improved reputation – These sus- its manufacturing processes and recyc- water consumption by 25%; reduction the requirements of Responsible Care,
Several steps have been taken to chemistry processes, which require tainability measures help the com- ling more waste materials. in energy consumption by 15%; reduc- a global programme that promotes
reduce the water consumption in less number of chemicals as raw panies to improve their reputation tion in waste generation by 20%; and environmental, health, and safety per-
different processes in pharmaceu- materials, and reduced number of in the eyes of their investors as well Sun Pharma has installed solar generation of 20% of the company’s formance in the chemical industry.
tical manufacturing plants. Instal- reaction steps. This also includes as the general public. By being seen panels at its manufacturing facilities energy needs from renewable sources.
lation of water-saving devices at utilisation of less toxic chemicals as sustainable companies, they can in India and the USA. It is also using Similar to other pharmaceutical
appropriate locations and recycling and solvents, as well as identifying attract more customers and inves- energy-effi cient equipment in its pro- Dr. Reddy’s Laboratories (DRL) companies, Cipla also has set ambitious
used water after suitable purifi ca- ways to recycle and reuse waste tors. cess plants. Sun Pharma is also work- DRL reported a sales turnover of targets to reduce its carbon emissions,
tion techniques have been used to materials. Boost to innovation – The efforts ing to reduce its waste generation and over Rs. 24,500-crores in 2022-23. The water consumption, and waste genera-
reduce the net water consumption to achieve sustainability goals give improve its energy effi ciency. company has implemented a number of tion. The company aims to achieve car-
in manufacturing processes. Additionally, the Indian pharma- a boost to innovation within these initiatives to reduce its environmental bon neutrality, water neutrality and zero
3. Reduction in waste generation – ceutical companies are also working pharmaceutical companies. Increa- In addition to the above measures, impact, improve social well-being and waste to landfi ll by 2025. Cipla has
Indian pharmaceutical companies on improving their social sustainability sed innovation fi nds new ways Sun Pharma is also working on a num- promote good governance. DRL is a implemented many initiatives to achieve
have taken various measures to initiatives; including providing access to reduce their environmental ber of other sustainability initiatives, signatory to the United Nations Global these targets, including, investments in
reduce generation of waste in their to healthcare for undeserved communi- impact. such as, developing sustainable pro- Compact, which is a voluntary initia- renewable energy sources, such as solar
manufacturing plants, especially ties through free or low-cost medicines Improvement in employee morale – ducts and packaging, promoting sustain- tive for businesses to align their ope- and wind power; implementing water
through recycling and reusing the and development of new healthcare Due to increased sustainability and able practices among its suppliers, rations and strategies with ten univer- conservation measures, such as rain-
waste raw materials and products facilities; supporting sustainable agri- commitment to sustainability of the increasing the awareness of sustainabi- sally accepted principles in the areas of water harvesting and recycling; and redu-
or by-products. Many companies culture, for example, through organic companies, their employees morale lity among its employees and custo- human rights, labour, environment and cing waste generation through process
have modifi ed their manufacturing farming; supporting education and is also improved. This leads to in- mers, etc. anti-corruption. The company is also optimization and recycling. It is also
processes to achieve zero waste. training programmes, and promoting creased happiness and productivity committed to continuous improvement implementing zero-liquid-discharge
4. Energy effi ciency improvements – gender equality. of the workforce. Divi’s Laboratories in its sustainability performance. (ZLD) systems at some of its manufac-
Domestic pharmaceutical com- Divi’s Laboratories is one of the turing sites. The company has reduced
panies have improved the energy Such sustainability efforts have led Through these developments, the world’s leading manufacturers of APIs DRL has set ambitious targets to its carbon emissions by 25% and its
effi ciency of their manufacturing to several benefi ts for these pharmaceu- Indian pharmaceutical companies are with annual sales turnover of over reduce its carbon emissions and water water consumption by 15% in the past
facilities through measures such tical companies. proving that it is possible to make a Rs. 24,600 crores. It has set ambitious tar- consumption. It aims to achieve use of fi ve years. In 2022, Cipla installed a 30
174 Chemical Weekly October 31, 2023 Chemical Weekly October 31, 2023 175
Contents Index to Advertisers Index to Products Advertised